References
- Zhao Q, Yan T, Chopp M, et al. Brain-kidney interaction: renal dysfunction following ischemic stroke. J Cereb Blood Flow Metab. 2020;40(2):246–262. doi:10.1177/0271678X19890931
- Wang D, Liu M, Hao Z, et al. Association between reduced kidney function and clinical outcomes after ischaemic stroke with atrial fibrillation. Eur J Neurol. 2014;21(1):160–166. doi:10.1111/ene.12293
- Wu VC, Wu PC, Wu CH, et al. The impact of acute kidney injury on the long-term risk of stroke. J Am Heart Assoc. 2014;3:e000933. doi:10.1161/JAHA.114.000933
- Zorrilla-Vaca A, Ziai W, Connolly ES, et al. Acute kidney injury following acute ischemic stroke and intracerebral hemorrhage: a meta-analysis of prevalence rate and mortality risk. Cerebrovasc Dis. 2018;45(1–2):1–9. doi:10.1159/000479338
- Tsagalis G, Akrivos T, Alevizaki M, et al. Long-term prognosis of acute kidney injury after first acute stroke. Clin J Am Soc Nephrol. 2009;4(3):616–622. doi:10.2215/CJN.04110808
- Tummalapalli SL, Estrella MM. Predicting risk of kidney disease: is risk-based kidney care on the horizon? JAMA. 2019;322(21):2079–2081. doi:10.1001/jama.2019.17378
- Nelson RG, Grams ME, Ballew SH, et al. Development of risk prediction equations for incident chronic kidney disease. JAMA. 2019;322(21):2104–2114. doi:10.1001/jama.2019.17379
- Chien KL, Lin HJ, Lee BC, et al. A prediction model for the risk of incident chronic kidney disease. Am J Med. 2010;123(9):836–846.e832. doi:10.1016/j.amjmed.2010.05.010
- O’Seaghdha CM, Lyass A, Massaro JM, et al. A risk score for chronic kidney disease in the general population. Am J Med. 2012;125(3):270–277. doi:10.1016/j.amjmed.2011.09.009
- Wang Y, Jing J, Meng X, et al. The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics. Stroke Vasc Neurol. 2019;4(3):158–164. doi:10.1136/svn-2019-000242
- Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35–41. doi:10.1161/01.STR.24.1.35
- Draznin B, Aroda VR, Bakris G, et al. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S17–S38.
- Carey RM, Wright JT, Taler SJ, et al. Guideline-driven management of hypertension: an evidence-based update. Circ Res. 2021;128(7):827–846. doi:10.1161/CIRCRESAHA.121.318083
- Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612. doi:10.7326/0003-4819-150-9-200905050-00006
- Luo Y, Wang X, Wang Y, et al. Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry. Diabetes Care. 2014;37:173–179. doi:10.2337/dc13-1931
- Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713–735. doi:10.1053/j.ajkd.2014.01.416
- Hayden D, McCarthy C, Akijian L, et al. Renal dysfunction and chronic kidney disease in ischemic stroke and transient ischemic attack: a population-based study. Int J Stroke. 2017;12(7):761–769. doi:10.1177/1747493017701148
- Putaala J, Haapaniemi E, Gordin D, et al. Factors associated with impaired kidney function and its impact on long-term outcome in young ischemic stroke. Stroke. 2011;42(9):2459–2464. doi:10.1161/STROKEAHA.110.612721
- Fandler-Höfler S, Odler B, Kneihsl M, et al. Acute and chronic kidney dysfunction and outcome after stroke thrombectomy. Transl Stroke Res. 2021;12(5):791–798. doi:10.1007/s12975-020-00881-2
- Kelly DAO, Li L, Burgess AI, et al. Associations of blood biomarkers with glomerular filtration rate in patients with TIA and stroke: population-based study. Stroke Vasc Neurol. 2021;6(1):48–56. doi:10.1136/svn-2020-000422
- Shimoyama T, Sato T, Sakamoto Y, et al. Urinary biomarkers of kidney tubule injury, risk of acute kidney injury, and mortality in patients with acute ischaemic stroke treated at a stroke care unit. Eur J Neurol. 2020;27(12):2463–2472. doi:10.1111/ene.14448
- Tao Y, Dong W, Li Z, et al. Proteinuria as an independent risk factor for contrast-induced acute kidney injury and mortality in patients with stroke undergoing cerebral angiography. J Neurointerv Surg. 2017;9:445–448. doi:10.1136/neurintsurg-2016-012349
- Ikeme JC, Pergola PE, Scherzer R, et al. Cerebral white matter hyperintensities, kidney function decline, and recurrent stroke after intensive blood pressure lowering: results from the secondary prevention of small subcortical strokes (SPS 3) trial. J Am Heart Assoc. 2019;8:e010091. doi:10.1161/JAHA.118.010091
- Lin SY, Tang SC, Tsai LK, et al. Incidence and risk factors for acute kidney injury following mannitol infusion in patients with acute stroke: a retrospective cohort study. Medicine. 2015;94:e2032. doi:10.1097/MD.0000000000002032
- Kamouchi M, Sakai H, Kiyohara Y, et al. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry. J Stroke Cerebrovasc Dis. 2013;22(8):e470–e476. doi:10.1016/j.jstrokecerebrovasdis.2013.05.018
- Qureshi AI, Aslam H, Zafar W, et al. Acute kidney injury in acute ischemic stroke patients in clinical trials. Crit Care Med. 2020;48:1334–1339. doi:10.1097/CCM.0000000000004464
- Demel SL, Grossman AW, Khoury JC, et al. Association between acute kidney disease and intravenous dye administration in patients with acute stroke: a population-based study. Stroke. 2017;48:835–839. doi:10.1161/STROKEAHA.116.014603
- Gadalean F, Simu M, Parv F, et al. The impact of acute kidney injury on in-hospital mortality in acute ischemic stroke patients undergoing intravenous thrombolysis. PLoS One. 2017;12:e0185589. doi:10.1371/journal.pone.0185589
- Stuveling EM, Hillege HL, Bakker SJ, et al. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003;63(2):654–661. doi:10.1046/j.1523-1755.2003.00762.x
- Wang HR, Chen DL, Zhao M, et al. C-reactive protein induces interleukin-6 and thrombospondin-1 protein and mRNA expression through activation of nuclear factor-ĸB in HK-2 cells. Kidney Blood Press Res. 2012;35:211–219. doi:10.1159/000332402
- Lee BT, Ahmed FA, Hamm LL, et al. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease. BMC Nephrol. 2015;16:77. doi:10.1186/s12882-015-0068-7
- Rhyu DY, Yang Y, Ha H, et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005;16:667–675. doi:10.1681/ASN.2004050425
- Tan RJ, Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Renal Physiol. 2012;302:F1351–F1361. doi:10.1152/ajprenal.00037.2012
- Krowicki ZK, Kapusta DR. Microinjection of glycine into the hypothalamic paraventricular nucleus produces diuresis, natriuresis, and inhibition of central sympathetic outflow. J Pharmacol Exp Ther. 2011;337:247–255. doi:10.1124/jpet.110.175398
- Mracsko E, Liesz A, Karcher S, et al. Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke. Brain Behav Immun. 2014;41:200–209. doi:10.1016/j.bbi.2014.05.015
- Zhang W, Wang W, Yu H, et al. Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage. Hypertension. 2012;59:136–144. doi:10.1161/HYPERTENSIONAHA.111.173328
- Puddu P, Puddu GM, Cravero E, et al. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol. 2010;26(4):140–145. doi:10.1016/S0828-282X(10)70371-8
- Venkat P, Chen J, Chopp M. Exosome-mediated amplification of endogenous brain repair mechanisms and brain and systemic organ interaction in modulating neurological outcome after stroke. J Cereb Blood Flow Metab. 2018;38:2165–2178. doi:10.1177/0271678X18782789
- Zhang W, Zhou X, Zhang H, et al. Extracellular vesicles in diagnosis and therapy of kidney diseases. Am J Physiol Renal Physiol. 2016;311(5):F844–F851. doi:10.1152/ajprenal.00429.2016
- van Overbeek EC, Staals J, van Oostenbrugge RJ. Decreased kidney function relates to progression of cerebral microbleeds in lacunar stroke patients. Int J Stroke. 2016;11(6):695–700. doi:10.1177/1747493016641966